X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-approves-sanofis-dupixent-smokers-lungs-2024-07-03/
https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-regeneron-pharmaceuticals-inc-to-contact-law-firm-302188091.html
https://www.globenewswire.com/news-release/2024/06/28/2905764/0/en/Odronextamab-Recommended-for-EU-Approval-by-the-CHMP-to-Treat-Relapsed-Refractory-Follicular-Lymphoma-and-Diffuse-Large-B-cell-Lymphoma.html
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-verona-pharmas-therapy-smokers-lungs-2024-06-26/
https://www.globenewswire.com/news-release/2024/06/27/2905523/0/en/Regeneron-to-Report-Second-Quarter-2024-Financial-and-Operating-Results-and-Host-Conference-Call-and-Webcast-on-August-1-2024.html
https://www.reuters.com/business/healthcare-pharmaceuticals/bayers-pharmaceutical-unit-plans-more-managerial-cuts-europe-asia-2024-06-26/
https://www.globenewswire.com/news-release/2024/06/26/2904848/0/en/Dupixent-dupilumab-Positive-Phase-3-Data-in-Children-1-to-11-Years-of-Age-with-Eosinophilic-Esophagitis-Published-in-the-New-England-Journal-of-Medicine.html
https://www.fiercebiotech.com/biotech/arrowhead-axes-1-heart-disease-drug-goes-all-another-pipeline-progress-drives-costs
https://www.fiercebiotech.com/biotech/intellia-doesnt-need-re-dose-gene-edited-ntla-2001-new-data-shows-it-can-be-done
https://www.globenewswire.com/news-release/2024/06/16/2899285/0/en/Updated-Linvoseltamab-Data-Showcase-Continued-Deepening-of-Responses-in-Patients-with-Heavily-Pre-Treated-Multiple-Myeloma.html
Market Place
Share 
